Osphena

Chemical Nameospemifene
Dosage FormTablet (oral; 60mg)
Drug ClassModulators
SystemFemale reproductive
CompanyDuchesnay Inc.
Approval Year2013

Indication

  • For the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
  • For the treatment of moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy, due to menopause.
Last updated on 4/29/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Osphena (ospemifene) Prescribing Information 2013Duchesnay USA, Inc., Bryn Mawr, PA